Here’s a great new video from Siim Land, regarding him being ranked #1 in the Longevity World Cup. Some noteworthy points include:
- His blood markers are similar to that of a 10-year old (it isn’t a cherry picked panel either).
- There’s a good discussion of Bortz Age, Pheno Age, and the Dunedin Clock.
- Siim believes that “being lean” is one of the most important drivers of his success.
- Diet - potatoes, cottage cheese, fish (cod/salmon), beef, a few eggs per week, berries, fruit, vegetables, whole grains, dark chocolate, nuts, seeds, beans, and greens.
- Macros - 120-135g of protein, 250-300g of carbs, 70-85g of fat, 40g of fibre.
- Exercise - 3-4x per week with calisthenics, favouring short/intense workouts (with some zone 2/5 cardio, as indicated in the comments).
- Sleep - 7-8 hours/night.
- Walking - 8 700 - 10 000 steps per day.
- Supplements - collagen, glycine, astaxanthin, lutein, zeaxanthin, vitamin d, vitamin k2, and omega 3.
Perhaps what stands out the most to me is that there isn’t a crazy amount of optimization required for him to achieve this. Just hitting the big movers and not getting lost in the minutiae.
I. Executive Summary
The core thesis of this discourse evaluates the clinical validity, predictive utility, and practical application of blood-biomarker-based biological age clocks—specifically the 22-marker Bortz Age clock and the 9-marker PhenoAge clock—as superior, actionable alternatives to epigenetic DNA methylation metrics for tracking systemic healthspan and mortality risk. Standardized phenotypic blood marker panels reflect real-time functional output across multi-organ pathways, including hepatic, renal, metabolic, and immunological axes, enabling targeted lifestyle modifications to reverse biological decline.
Analysis of large-scale epidemiological data, notably within the UK Biobank, demonstrates that the Bortz Age clock possesses a high concordance index (C-index = 0.778) for the stratification of mortality risk, outperforming standard PhenoAge models by roughly 11% (Bortz et al., 2023). This predictive resolution hinges on identifying key physiological patterns: high insulin sensitivity, minimal systemic chronic inflammation, robust immune signaling, and optimized filtration. A critical metabolic priority is maintaining low fasting glucose and hemoglobin A1C (HbA1C), which minimizes glycation-induced tissue stress (Levine et al., 2018). Concurrently, systemic chronic inflammation must be suppressed, targeting an optimal high-sensitivity C-reactive protein (hs-CRP) threshold of 0.1 mg/L or lower.
Renal evaluation requires a critical transition from serum creatinine to Cystatin C, as the former is profoundly confounded by total skeletal muscle mass and transient training-induced protein turnover, whereas Cystatin C serves as an unconfounded, stable index of true glomerular filtration rate (Shlipak et al., 2013). Hepatic optimization relies on managing total training volume and visceral fat accumulation; extreme physical training workloads paradoxically elevate transaminases (ALT, GGT), signaling localized muscle or liver tissue stress that can distort clock calculations. Mechanistically, achieving an optimized phenotypic profile requires navigating the boundary of moderate caloric restriction. While restriction optimizes glycemic and inflammatory markers, excess caloric deficits introduce a profound trade-off, precipitating immune system dampening, thyroid down-regulation, and sex hormone binding globulin (SHBG) abnormalities (Redman et al., 2018). Thus, a balanced framework requires lean body composition maintained through highly localized, high-intensity, low-volume resistance training, paired with a nutrient-dense, polyphenol-rich diet containing adequate protein and essential fatty acids, avoiding the systemic penalties of over-restriction.
II. Insight Bullets
- Longevity World Cup Benchmarks: The competition evaluates biological age reduction using two validated clinical blood-biomarker algorithms: the 22-marker Bortz Age clock and the 9-marker PhenoAge clock.
- Bortz Age Operational Scale: Trained on machine-learning cohorts, the Bortz Age clock estimates biological age by analyzing circulating markers of metabolic, cardiovascular, renal, hepatic, and immune function.
- UK Biobank Predictive Power: A 2023 cohort study validating the Bortz Age clock achieved a C-index of 0.778, demonstrating a 78% accuracy rate in ranking survival and mortality risk between individuals.
- Bortz vs. PhenoAge Accuracy: The Bortz Age clock adds 13 additional blood parameters to the standard PhenoAge matrix, yielding an 11% relative increase in disease and mortality predictive accuracy.
- PhenoAge Composition: Developed by Morgan Levine and colleagues, PhenoAge integrates chronological age with 9 multi-system clinical chemistry markers to determine a phenotypic mortality risk score.
- Phenotypic Age Disparity and Cancer: Longitudinal biobank data establish that individuals with a PhenoAge score 10 years higher than their chronological age experience accelerated mortality and elevated cancer risk.
- Chronological Age Co-dependency: Both phenotypic blood clocks integrate chronological age as a baseline weight, meaning older individuals can mathematically manifest larger biological age reduction deltas (e.g., 20-25 years) than younger cohorts.
- DunedinPACE Distinct Mechanics: Unlike blood-marker age clocks that output biological age in literal years, DunedinPACE is an epigenetic clock measuring the immediate rate or pace of biological aging.
- Blood Clocks vs. Epigenetic Flaws: Blood-biomarker clocks provide distinct actionable clarity; an adverse blood marker indicates exactly which organ system requires intervention, whereas an elevated epigenetic methylation score fails to locate the localized root physiological cause.
- Circadian Fluctuation Vulnerability: Epigenetic DNA methylation markers suffer from severe circadian fluctuations and can yield significantly divergent scores depending on morning versus evening sample collection.
- Fasted Blood Standardization: Blood-based phenotypic clocks rely on highly standardized, early-morning fasted collection protocols, eliminating transient postprandial confounding factors.
- The Insulin Sensitivity Imperative: The foundational metabolic requirement for a minimized biological age is maximized insulin sensitivity, marked by concurrently low fasting glucose, low fasting insulin, and low HbA1C.
- Apolipoprotein Ratios as Metabolic Proxies: Higher Apolipoprotein A (ApoA) reflects optimized insulin sensitivity and favorable lipid homeostasis, contrasting with the atherogenic profile of elevated Apolipoprotein B (ApoB).
- Immune Signaling Optimization: A high lymphocyte percentage reflects robust, active adaptive immune signaling, provided absolute white blood cell (WBC) counts remain low-to-normal to rule out acute infection or systemic autoimmunity.
- Systemic Inflammation Floor: High-sensitivity C-reactive protein (hs-CRP) should be driven as close to zero as possible; an optimal longevity target sits at or below 0.1 mg/L, whereas average unoptimized individuals score between 0.5 and 1.5 mg/L.
- Visceral Fat and Transaminase Elevations: Excess visceral fat accumulation and elevated systemic triglycerides drive pathological increases in liver transaminases (ALT, ALP, GGT), signaling localized hepatic distress.
- Exercise Volume Confounders on Hepatic Markers: Intense, high-volume physical training regimes can artificially elevate liver transaminases due to systemic tissue turnover; reducing total weekly training volume can rapidly normalize ALT and GGT levels.
- Cystatin C Superiority: Cystatin C is a highly reliable, unconfounded biomarker of glomerular filtration rate (GFR) because, unlike creatinine, it is completely independent of total skeletal muscle mass, protein intake, and acute exercise.
- Creatinine Limitations: Serum creatinine metrics can be profoundly misleading in muscular athletes or individuals with high protein turnover, falsely indicating impaired kidney function when actual GFR is optimal.
- Albumin as a Nutritional Status Index: Higher serum albumin values within the normal clinical range reflect robust protein status, optimal caloric adequacy, and low systemic inflammatory depletion.
- The Caloric Restriction Boundary Line: Maintaining a state on the borderline of moderate caloric restriction optimizes metabolic, inflammatory, and hepatic biomarkers, but crossing into excessive restriction carries significant biological penalties.
- Pathological Over-Restriction Penalties: Excessive caloric restriction induces systemic biological dysfunction, down-regulating thyroid output, dampening the adaptive immune system, lowering sex hormones, and degrading exercise output.
- High-Intensity Low-Volume Resistance Framework: Executing short, high-intensity resistance workouts (e.g., 20 minutes, 2-3 sets to true failure using calisthenics or a weighted vest) preserves skeletal muscle mass while avoiding the transaminase and protein-turnover spikes seen in high-volume training.
- Polyphenol-Dense Nutrient Profile: Minimizing visceral fat while maintaining lean mass is optimized via a diet prioritizing clean carbohydrate blocks (potatoes, whole grains), high-quality proteins (cottage cheese, cod, salmon, beef), and abundant whole-food antioxidants (berries, dark chocolate).
- Targeted Baseline Supplementation: Achieving an optimal biomarker profile can be supported by low-complexity, targeted supplementation consisting of glycine, astaxanthin, carotenoids (lutein/zeaxanthin), high-dose vitamin D3/K2, collagen peptides, and highly concentrated omega-3 fatty acids.
IV. Actionable Protocol (Prioritized)
High Confidence Tier (Level A/B Evidence)
- Multi-System Biological Age Risk Stratification: Utilize comprehensive blood biomarker panel analysis (incorporating the 22 core elements of the Elastic-Net derived Cox model) rather than relying solely on isolated single-organ markers. Systematic tracking provides a highly accurate method for scoring multi-organ physiological deterioration and overall mortality risk (Bortz et al., 2023).
- Unconfounded Renal Assessment (Cystatin C): Replace or supplement serum creatinine tests with Cystatin C measurements to assess true glomerular filtration rate (GFR). Creatinine is heavily confounded by skeletal muscle volume, creatine supplementation, and high-intensity exercise turnover, whereas Cystatin C functions as a stable, linear predictor of all-cause mortality across diverse clinical cohorts (Shlipak et al., 2013).
- Moderate Caloric Optimization without Malnutrition: Maintain lean mass metrics on the upper boundary of caloric restriction (~11% to 15% energy deficit). Controlled clinical trials verify that moderate restriction decreases tissue oxidative damage and systematically lowers fasting blood glucose, HbA1C, and systemic inflammatory markers without introducing clinical adverse events (Kraus et al., 2019).
Experimental Tier (Level C/D Evidence)
- Low-Volume, High-Intensity Neuromuscular Stimulation: Restructure resistance training into compressed, ultra-intense sessions (e.g., 20 minutes total, 2 to 3 working sets executed to absolute muscular failure using calisthenics or a weighted vest) to stimulate muscle protein synthesis while keeping liver transaminase spikes low.
- Fasted Baseline Blood Standardization: Conduct all phenotype blood draws in an absolute early-morning fasted state to stabilize circadian-driven metabolic variables, ensuring internal consistency across sequential evaluations.
-
Polyphenol and Micronutrient Dense Dietary Pattern: Structure daily macronutrient distribution to prioritize clean complex carbohydrates (400g potatoes), high-yielding lean proteins (cottage cheese, cod, salmon, beef), and daily fiber blocks (40g total, augmented by 10g psyllium husk), while integrating a concise, targeted longevity stack:
- Glycine: 5 to 10 grams daily for endogenous glutathione synthesis support.
- Astaxanthin: 12 mg daily for specialized lipid-membrane antioxidant shielding.
- Vitamin D3 + K2: 5,000 IU D3 combined with 120 mcg K2 to stabilize immune cells and calcium routing.
- High-Concentration Omega-3 Fatty Acids: 2,000 to 3,000 mg daily to depress hyper-inflammatory eicosanoid pathways.
